Hence, stratification of tumor types by PIK3CA or PTEN mutations or expression, in combination with the mTOR activity status, could provide additional information concerning disease prognosis as well as potential sensitivity or resistance to cancer treatments. This evidence concerns the gene MTOR and neoplasm.